These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 35640539)
1. EIF5A2 Is Involved in the Biological Process of Cervical Cancer Cells through AGR2. Shen X; Li L; He Y; Lv X; Ma J Pharmacology; 2022; 107(7-8):376-385. PubMed ID: 35640539 [TBL] [Abstract][Full Text] [Related]
2. Sonic Hedgehog-GLI Family Zinc Finger 1 Signaling Pathway Promotes the Growth and Migration of Pancreatic Cancer Cells by Regulating the Transcription of Eukaryotic Translation Initiation Factor 5A2. Xu X; Liu H; Zhang H; Dai W; Guo C; Xie C; Wei S; He S; Xu X Pancreas; 2015 Nov; 44(8):1252-8. PubMed ID: 26465952 [TBL] [Abstract][Full Text] [Related]
3. Overexpression of eukaryotic initiation factor 5A2 (EIF5A2) is associated with cancer progression and poor prognosis in patients with early-stage cervical cancer. Yang SS; Gao Y; Wang DY; Xia BR; Liu YD; Qin Y; Ning XM; Li GY; Hao LX; Xiao M; Zhang YY Histopathology; 2016 Aug; 69(2):276-87. PubMed ID: 26799253 [TBL] [Abstract][Full Text] [Related]
4. Eukaryotic translation initiation factor 5A2 regulates the migration and invasion of hepatocellular carcinoma cells via pathways involving reactive oxygen species. Liu RR; Lv YS; Tang YX; Wang YF; Chen XL; Zheng XX; Xie SZ; Cai Y; Yu J; Zhang XN Oncotarget; 2016 Apr; 7(17):24348-60. PubMed ID: 27028999 [TBL] [Abstract][Full Text] [Related]
5. MiR-30b suppresses tumor migration and invasion by targeting EIF5A2 in gastric cancer. Tian SB; Yu JC; Liu YQ; Kang WM; Ma ZQ; Ye X; Yan C World J Gastroenterol; 2015 Aug; 21(31):9337-47. PubMed ID: 26309359 [TBL] [Abstract][Full Text] [Related]
6. Overexpression of eukaryotic translation initiation factor 5A2 (EIF5A2) correlates with cell aggressiveness and poor survival in gastric cancer. Meng QB; Kang WM; Yu JC; Liu YQ; Ma ZQ; Zhou L; Cui QC; Zhou WX PLoS One; 2015; 10(3):e0119229. PubMed ID: 25793713 [TBL] [Abstract][Full Text] [Related]
7. Knockdown of eukaryotic translation initiation factor 5A2 enhances the therapeutic efficiency of doxorubicin in hepatocellular carcinoma cells by triggering lethal autophagy. Tang Y; Chen K; Luan X; Zhang J; Liu R; Zheng X; Xie S; Ke H; Zhang X; Chen W Int J Oncol; 2020 Dec; 57(6):1368-1380. PubMed ID: 33174013 [TBL] [Abstract][Full Text] [Related]
8. Blocking Modification of Eukaryotic Initiation 5A2 Antagonizes Cervical Carcinoma via Inhibition of RhoA/ROCK Signal Transduction Pathway. Liu X; Chen D; Liu J; Chu Z; Liu D Technol Cancer Res Treat; 2017 Oct; 16(5):630-638. PubMed ID: 27609633 [TBL] [Abstract][Full Text] [Related]
10. Role of EIF5A2, a downstream target of Akt, in promoting melanoma cell invasion. Khosravi S; Wong RP; Ardekani GS; Zhang G; Martinka M; Ong CJ; Li G Br J Cancer; 2014 Jan; 110(2):399-408. PubMed ID: 24178756 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-383 inhibits doxorubicin resistance in hepatocellular carcinoma by targeting eukaryotic translation initiation factor 5A2. Tu C; Chen W; Wang S; Tan W; Guo J; Shao C; Wang W J Cell Mol Med; 2019 Nov; 23(11):7190-7199. PubMed ID: 30801960 [TBL] [Abstract][Full Text] [Related]
12. Clinical significance of eukaryotic translation initiation factor 5A2 in papillary thyroid cancer. Zhang H; Zhang K; Ning L; Chen D; Hao F; Li P Bioengineered; 2020 Dec; 11(1):1325-1333. PubMed ID: 33200656 [TBL] [Abstract][Full Text] [Related]
13. Eukaryotic Initiation Factor 5A2 Contributes to the Maintenance of CD133(+) Hepatocellular Carcinoma Cells via the c-Myc/microRNA-29b Axis. Bai HY; Liao YJ; Cai MY; Ma NF; Zhang Q; Chen JW; Zhang JX; Wang FW; Wang CY; Chen WH; Jin XH; Xu RH; Guan XY; Xie D Stem Cells; 2018 Feb; 36(2):180-191. PubMed ID: 29119708 [TBL] [Abstract][Full Text] [Related]
14. [Effects of eukaryotic translation initiation factor 5A2 down-regulation by small interfering RNA on aggressiveness of MKN28 human]. Meng QB; Yu JC; Kang WM; Ma ZQ; Zhou L; Ye X; Cao ZJ; Tian SB Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2014 Oct; 36(5):482-7. PubMed ID: 25360644 [TBL] [Abstract][Full Text] [Related]
15. LINC00518 affects the proliferation, invasion and migration of cutaneous malignant melanoma cells via miR-526b-3p/EIF5A2 axis. Xu J; Zhang F; Lin M; Tong Y Acta Biochim Pol; 2022 Feb; 69(1):101-111. PubMed ID: 35189053 [TBL] [Abstract][Full Text] [Related]
16. YTHDF2 interference suppresses the EMT of cervical cancer cells and enhances cisplatin chemosensitivity by regulating AXIN1. Wu M; Chen G; Liao X; Xiao L; Zheng J Drug Dev Res; 2022 Aug; 83(5):1190-1200. PubMed ID: 35489084 [TBL] [Abstract][Full Text] [Related]
17. Eukaryotic translation initiation factor 5A2 promotes metabolic reprogramming in hepatocellular carcinoma cells. Cao TT; Lin SH; Fu L; Tang Z; Che CM; Zhang LY; Ming XY; Liu TF; Tang XM; Tan BB; Xiang D; Li F; Chan OY; Xie D; Cai Z; Guan XY Carcinogenesis; 2017 Jan; 38(1):94-104. PubMed ID: 27879277 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-588 regulates migration capacity and invasiveness of renal cancer cells by targeting EIF5A2. Dong JS; Wu B; Zha ZL Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10248-10256. PubMed ID: 31841179 [TBL] [Abstract][Full Text] [Related]
19. Increased expression of EIF5A2, via hypoxia or gene amplification, contributes to metastasis and angiogenesis of esophageal squamous cell carcinoma. Li Y; Fu L; Li JB; Qin Y; Zeng TT; Zhou J; Zeng ZL; Chen J; Cao TT; Ban X; Qian C; Cai Z; Xie D; Huang P; Guan XY Gastroenterology; 2014 Jun; 146(7):1701-13.e9. PubMed ID: 24561231 [TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA LINC00520 promotes the proliferation and metastasis of malignant melanoma by inducing the miR-125b-5p/EIF5A2 axis. Luan W; Ding Y; Yuan H; Ma S; Ruan H; Wang J; Lu F; Bu X J Exp Clin Cancer Res; 2020 May; 39(1):96. PubMed ID: 32466797 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]